Insmed Inc - Current report filing (8-K)
06 Novembre 2007 - 2:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 6, 2007
INSMED INCORPORATED
(Exact Name of
Registrant as Specified in Its Charter)
Virginia
(State or Other Jurisdiction of Incorporation)
|
|
|
0-30739
|
|
54-1972729
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
8720 Stony Point Parkway, Suite 200, Richmond, Virginia
|
|
23235
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
(804) 565-3000
(Registrants Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
INFORMATION TO BE INCLUDED IN THE REPORT
Section 8Other Events
On November 5, 2007 Insmed
Incorporated published a press release announcing initiation of a Phase II clinical trial of IPLEX in Myotonic Muscular Dystrophy. A copy of the press release is attached hereto as Exhibit 99.1.
The information contained herein, including the Exhibit attached hereto shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in
such a filing.
Item 9.01.
|
Financial Statements and Exhibits.
|
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release issued by Insmed Incorporated on November 5, 2007
|
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Insmed Incorporated
|
Date: November 6, 2007
|
|
|
|
|
|
|
By:
|
|
/s/ Kevin P. Tully
|
|
|
Name:
|
|
Kevin P. Tully C.G.A.,
|
|
|
Title:
|
|
Executive Vice President & Chief Financial Officer
|
- 3 -
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release issued by Insmed Incorporated on November 5, 2007
|
- 4 -
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024